This blog is coming across the woodland in stereo as the Diabetes and Mental Elf join forces. In 2011 the Diabetes Elf highlighted Depression and Diabetes: a two way street? a systematic review looking at cause and effect of diabetes and depression and the link between diabetes and cardiovascular disease is not contested. However moving forward [read the full story…]
Two of the most widely available medicines for dementia in the UK are cholinesterase inhibitors and a N-methyl-D-aspartate (NMDA) receptor antagonists (NHS, 2013). Both drugs are popular because they have been found to lead to improvements in dementia symptoms (Raina 2008). However, some have raised concerns about the safety for patients. These concerns are partly [read the full story…]
The Royal College of Psychiatrists has today published what they are calling a landmark report on achieving parity between mental and physical health. The report, Whole-Person Care: From Rhetoric to Reality, defines parity as valuing mental health equally with physical health. It highlights the significant inequalities that exist between physical and mental health care, including [read the full story…]
As the British Heart Foundation National Heart Month draws to a close Lifestyle Elf and I were discussing their blog on heart attacks not being reduced in people taking vitamins and antioxidants which led to us to thinking about the relationship between stress and cardiovascular disease (CVD). Our colleagues in the Pittsburgh Health Heart Project [read the full story…]
Since starting this blog two years ago, I have written about a number of studies that highlight the health inequalities faced by people with severe mental illness. The evidence keeps piling up and it’s really quite shocking that we are not doing more to diagnose and treat physical health problems in people with conditions such [read the full story…]
Chronic diseases and depression often go hand in hand. There is a growing evidence-base that shows how exercise can help reduce depressive symptoms in people with chronic illness and it’s encouraging to see a steady stream of primary research being published in this area. A new ancillary study published in JAMA examines the effect that [read the full story…]
The reduced life expectancy (15-20 years less) often faced by many people with schizophrenia is frequently a result of cardiovascular disease. Lifestyle choices (smoking, lack of exercise and poor diet) can increase the risk of these diseases, but people who take antipsychotic drugs often have the additional problem of weight gain that is caused by [read the full story…]
A year ago this week I blogged about a study in the British Journal of Psychiatry that showed the dramatically reduced life expectancy of people with severe mental illness, who on average live 15-20 years less than the rest of the population. Twelve months on and a new study published in the same journal paints an equally [read the full story…]
NICE have published public health guidance and a new care pathway to help people of South Asian origin who are living in England to stop using traditional South Asian varieties of smokeless tobacco. These publications are focused on people with ancestral links to Bangladesh, India, Nepal, Pakistan or Sri Lanka and smokeless tobacco products such [read the full story…]
Weight gain is one of the side effects that people who take antipsychotic drugs complain of the most. Obesity is common in this population and this can often lead to cardiovascular problems and a far shorter life expectancy than the rest of the population. As a result, there is a great deal of interest in [read the full story…]
